Newsfeed

Bei diesem Bereich handelt es sich um eine mögliche Darstellungsform der Integration von Nachrichtenquellen mit Bezug zu börsennotierten Unternehmen.
Als Präsentationsebene fungiert ein Template, dass an Kurznachrichtenservices angelehnt ist, bei dem sich Nutzer einen schnellen Überblick über aktuelle Nachrichten verschaffen können. Die Detailansichten ermöglichen bei Interesse weitergehende Recherchen.

Dieser Newsfeed ist eine Zusammenstellung aktueller Nachrichten, die aus Direktanbindungen von TopTier NewsWire-Services mit Bezug zu börsennotierten Unternehmen stammen. Dieser Feed hier dient ausschließlich Demonstrationszwecken. Sektoren-spezifische Nachrichten, Public Relations sowie Produktinformationen können über die GICS Portale > Bereich Sektor-Intelligence abgerufen werden.

US4330001060
Filter zurücksetzen
Do you already know our new terminal view? Click here.
FIGI: BBG00Q53VYM7
HIMS
Hims & Hers Health Inc
GICS: Health Care · SECTOR: EQTY · SUB-SECTOR: Household & Personal Products · THEMEFOLIO: $HLTH
NAME
Hims & Hers Health Inc
ISIN
US4330001060
TICKER
HIMS
MIC
XNYS
REUTERS
HIMS.N
BLOOMBERG
HIMS US
Mo., 09.03.2026       Hims & Hers Health
US4330001060

Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into Hims & Hers Health, Inc. (“Hims” or the “Company”) (NYSE: HIMS). On June 23, 2025, Novo Nordisk announced that it was terminating its partnership with Hims &...
Zur Nachricht
Hims & Hers Health
Charts & Research Termsheets Terminal
Permalink
Mo., 09.03.2026       Hims & Hers Health
US4330001060

Hims & Hers Health, Inc. (NYSE: HIMS) today announced a collaboration with Novo Nordisk as part of a new strategy for weight loss care treatments involving GLP-1s, evolving its US offering to match the company’s approach globally. In the US, the company now plans to provide GLP-1 customers with access to a broad assortment of FDA-approved medi...
Zur Nachricht
Hims & Hers Health
Charts & Research Termsheets Terminal
Permalink
Mo., 02.03.2026       Hims & Hers Health
US4330001060

Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, today announced that it is investigating potential claims against the board of directors of Hims & Hers Health, Inc. (“Hims” or the “Company”) (NYSE: HIMS) concerning whether the board breached its fiduciary duties to shareholders. IF YOU ARE A HIMS &...
Zur Nachricht
Hims & Hers Health
Charts & Research Termsheets Terminal
Permalink
Fr., 27.02.2026       Hims & Hers Health
US4330001060

Law Offices of Howard G. Smith announces it is investigating potential claims against the board of directors of Hims & Hers Health, Inc. (“Hims” or the “Company”) (NYSE: HIMS) concerning whether the board breached its fiduciary duties to shareholders. IF YOU ARE A HIMS & HERS HEALTH, INC. (HIMS) SHAREHOLDER, CONTACT THE LAW OFFICES OF HO...
Zur Nachricht
Hims & Hers Health
Charts & Research Termsheets Terminal
Permalink
Do., 26.02.2026       Hims & Hers Health
US4330001060

The Law Offices of Frank R. Cruz is investigating potential claims against the board of directors of Hims & Hers Health, Inc. (“Hims” or the “Company”) (NYSE: HIMS) concerning whether the board breached its fiduciary duties to shareholders. If you are a shareholder, click here to participate. On February 7, 2026, The New York Times reporte...
Zur Nachricht
Hims & Hers Health
Charts & Research Termsheets Terminal
Permalink
Mo., 23.02.2026       Hims & Hers Health
US4330001060

Hims & Hers Health, Inc. (“Hims & Hers” or the “Company”, NYSE: HIMS), the leading health and wellness platform, today announced financial results for the fourth quarter and full year ended December 31, 2025 in a shareholder letter that is posted at investors.hims.com. “More than 2.5 million subscribers now rely on us for a healthcare ex...
Zur Nachricht
Hims & Hers Health
Charts & Research Termsheets Terminal
Permalink
Do., 19.02.2026       Hims & Hers Health
US4330001060

Hims & Hers Health, Inc. (NYSE: HIMS), the leading health and wellness platform, today announced it has entered into a definitive agreement to acquire Eucalyptus, an international leader in digital health, accelerating the company’s ability to bring access to high-quality, personalized care to more people across the world. As its US business c...
Zur Nachricht
Hims & Hers Health
Charts & Research Termsheets Terminal
Permalink
Mo., 09.02.2026       Hims & Hers Health
US4330001060

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Hims & Hers Health, Inc. (“Hims & Hers” or “the Company”) (NYSE: HIMS) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements an...
Zur Nachricht
Hims & Hers Health
Charts & Research Termsheets Terminal
Permalink
Do., 05.02.2026       Hims & Hers Health
US4330001060

Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the leading health and wellness platform, today announced an expansion of its weight loss specialty by enabling providers to prescribe a Compounded Semaglutide Pill with the same active ingredient as Wegovy®**. This needle-free treatment joins a full suite of weight loss solutions desig...
Zur Nachricht
Hims & Hers Health
Charts & Research Termsheets Terminal
Permalink
Mi., 04.02.2026       Hims & Hers Health
US4330001060

Today, Hims & Hers Health, Inc. (NYSE: HIMS), the leading digital health and wellness platform, launched access to the Hims & Hers Multi-Cancer Test by Galleri®, a simple cancer screening blood test that can detect a signal for 50+ types of cancer even before symptoms appear1. This multi-cancer early detection (MCED) test combines Hims &am...
Zur Nachricht
Hims & Hers Health
Charts & Research Termsheets Terminal
Permalink
Silent Ad
Mo., 02.02.2026       Hims & Hers Health
US4330001060

Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the leading health and wellness platform, today announced that it will report fourth quarter and full year 2025 financial results after the market closes on Monday, February 23, 2026. The company will host a live conference call to discuss the results at 5:00 p.m. ET the same day. The...
Zur Nachricht
Hims & Hers Health
Charts & Research Termsheets Terminal
Permalink
Do., 29.01.2026       Hims & Hers Health
US4330001060

Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the leading health and wellness platform, announced that it’s heading back to the Big Game this year. On February 8th, Hims & Hers will follow up its hit “Sick of the System” ad, debuting a new national spot “Rich People Live Longer” with a simple message: the era of health as a lux...
Zur Nachricht
Hims & Hers Health
Charts & Research Termsheets Terminal
Permalink
Mi., 10.12.2025       Hims & Hers Health
US4330001060

Hims & Hers is deepening its commitment to the UK by bringing access to its comprehensive Weight Loss Programme to customers. This expansion includes the official introduction of the Hers platform, helping eligible women across the UK receive access to this holistic weight management care. This press release features multimedia. View the full...
Zur Nachricht
Hims & Hers Health
Charts & Research Termsheets Terminal
Permalink
Do., 04.12.2025       Hims & Hers Health
US4330001060

Hims & Hers Health, Inc. (NYSE: HIMS), the leading health and wellness platform in the United States, is now serving customers in Canada. This entry follows the recent completion of Hims & Hers’ acquisition of Livewell, a trusted Canadian digital health platform offering access to a variety of treatments, with a focus on weight loss. Build...
Zur Nachricht
Hims & Hers Health
Charts & Research Termsheets Terminal
Permalink
Do., 04.12.2025       Hims & Hers Health
US4330001060

Hims & Hers Health, Inc. (NYSE: HIMS), the leading health and wellness platform in the United States, is now serving customers in Canada. This entry follows the recent acquisition of Livewell, a trusted Canadian digital health platform focused on weight loss. Through this expansion, Hims & Hers is well-positioned to usher in the next era o...
Zur Nachricht
Hims & Hers Health
Charts & Research Termsheets Terminal
Permalink
Mi., 03.12.2025       Hims & Hers Health
US4330001060

Hims & Hers Health, Inc. (NYSE: HIMS), the leading health and wellness platform, today announced that it has entered into a definitive agreement to acquire YourBio Health, Inc., a Boston-based pioneer in capillary whole blood sampling technology. Powered by YourBio’s advanced blood sampling devices, the acquisition will help accelerate efforts...
Zur Nachricht
Hims & Hers Health
Charts & Research Termsheets Terminal
Permalink
Mo., 17.11.2025       Hims & Hers Health
US4330001060

Hims & Hers Health, Inc. (“Hims & Hers” or the “Company,” NYSE: HIMS), the leading health and wellness platform, today announced that its Board of Directors has authorized a share repurchase program of up to $250 million of outstanding Class A common stock over the next three years. This new program follows the successful completion of the...
Zur Nachricht
Hims & Hers Health
Charts & Research Termsheets Terminal
Permalink
Mo., 17.11.2025       Hims & Hers Health
US4330001060

Hims & Hers Health, Inc. (NYSE: HIMS), the leading health and wellness platform, today announced the appointment of Deb Autor as the company’s first Chief Policy Officer. In this new role, Autor will collaborate with other stakeholders, including consumers, telehealth platforms, providers, advocacy groups, medical associations, pharmaceutical...
Zur Nachricht
Hims & Hers Health
Charts & Research Termsheets Terminal
Permalink
Do., 13.11.2025       Hims & Hers Health
US4330001060

Hims & Hers Health, Inc. (NYSE: HIMS), the leading health and wellness platform, today announced the launch of Labs, a new way for customers to understand their overall health and identify ways to improve and maintain it. Labs measures key markers over time and provides doctor-developed action plans that can power real shifts in health outcome...
Zur Nachricht
Hims & Hers Health
Charts & Research Termsheets Terminal
Permalink
Mo., 03.11.2025       Hims & Hers Health
US4330001060

Hims & Hers Health, Inc. (“Hims & Hers” or the “Company”, NYSE: HIMS), the leading health and wellness platform, today announced financial results for the third quarter ended September 30, 2025, in a shareholder letter that is posted at investors.hims.com. “This quarter we continued to prove that our vision of helping tens of millions of...
Zur Nachricht
Hims & Hers Health
Charts & Research Termsheets Terminal
Permalink
Silent Ad
Mi., 29.10.2025       Hims & Hers Health
US4330001060

NEW YORK, Oct. 29, 2025 /PRNewswire/ -- A securities fraud class action lawsuit against Hims & Hers Health, Inc. (NYSE: HIMS) is pending. The lawsuit was filed by Glancy Prongay & Murray LLP. Previous press releases stated incorrectly that Levi & Korsinsky filed the case. This press release makes that...
Zur Nachricht
Hims & Hers Health
Charts & Research Termsheets Terminal
Permalink
Mi., 15.10.2025       Hims & Hers Health
US4330001060

Hims & Hers Health, Inc. (NYSE: HIMS), the leading health and wellness platform, today announced the launch of a new specialty in women’s health, offering access to affordable treatment plans built specifically for women experiencing perimenopause and menopause. Starting today, women can work with a provider on the platform to access treatment...
Zur Nachricht
Hims & Hers Health
Charts & Research Termsheets Terminal
Permalink
Mo., 13.10.2025       Hims & Hers Health
US4330001060

Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the leading health and wellness platform, today announced that it will report third quarter 2025 financial results after the market closes on Monday, November 3, 2025. The company will host a live conference call to discuss the results at 5:00 p.m. ET the same day. The conference call...
Zur Nachricht
Hims & Hers Health
Charts & Research Termsheets Terminal
Permalink
Do., 09.10.2025       Hims & Hers Health
US4330001060

Hims & Hers Health, Inc. (NYSE: HIMS) today published a new white paper - Understanding Hims & Hers Approach to Clinical Excellence, Quality, and Safety - detailing how rigorous standards, continuous monitoring, and customer-centered design are shaping the future of safe and effective telehealth. “At Hims & Hers, we believe that digi...
Zur Nachricht
Hims & Hers Health
Charts & Research Termsheets Terminal
Permalink
Fr., 03.10.2025       Hims & Hers Health
US4330001060

PHILADELPHIA, Oct. 3, 2025 /PRNewswire/ -- Berger Montague, a national securities litigation law firm, advises shareholders of Hims & Hers Health Inc. ("Hims & Hers" or the "Company") (NYSE: HIMS) about an investigation into Hims & Hers' Board of Directors for potential breaches of fiduciary duties to...
Zur Nachricht
Hims & Hers Health
Charts & Research Termsheets Terminal
Permalink
Mi., 24.09.2025       Hims & Hers Health
US4330001060

NEW YORK, Sept. 24, 2025 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Hims & Hers Health, Inc.  (NYSE: HIMS) breached their fiduciary duties to shareholders. ...
Zur Nachricht
Hims & Hers Health
Charts & Research Termsheets Terminal
Permalink
Fr., 19.09.2025       Hims & Hers Health
US4330001060

PHILADELPHIA, Sept. 19, 2025 /PRNewswire/ -- Berger Montague, a national securities litigation law firm, advises shareholders of Hims & Hers Health Inc. ("Hims & Hers" or the "Company") (NYSE: HIMS) about an investigation into Hims & Hers' Board of Directors for potential breaches of fiduciary duties to the Company and its shareholder...
Zur Nachricht
Hims & Hers Health
Charts & Research Termsheets Terminal
Permalink
Mo., 15.09.2025       Hims & Hers Health
US4330001060

PHILADELPHIA, Sept. 15, 2025 /PRNewswire/ -- Berger Montague, a national securities litigation law firm, advises shareholders of Hims & Hers Health Inc. ("Hims & Hers" or the "Company") (NYSE: HIMS) about an investigation into Hims & Hers' Board of Directors for potential breaches of fiduciary duties to the Company and its shareholder...
Zur Nachricht
Hims & Hers Health
Charts & Research Termsheets Terminal
Permalink
Mi., 10.09.2025       Hims & Hers Health
US4330001060

Hims & Hers Health, Inc. (NYSE: HIMS), the leading health and wellness platform, today announced the launch of a new category in men’s health, offering access to innovative, affordable, and personalized treatment plans for low testosterone. This press release features multimedia. View the full release here: https://www.businesswire.com/news/h...
Zur Nachricht
Hims & Hers Health
Charts & Research Termsheets Terminal
Permalink
Mo., 25.08.2025       Hims & Hers Health
US4330001060

Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Hims & Hers Health, Inc. (“Hims” or the “Company”) (NYSE: HIMS) and reminds investors of the August 25, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. Faru...
Zur Nachricht
Hims & Hers Health
Charts & Research Termsheets Terminal
Permalink
Mo., 25.08.2025       Hims & Hers Health
US4330001060

NEW YORK, Aug. 25, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Hims & Hers Health, Inc. (NYSE: HIMS). Shareholders who purchased shares of HIMS during the class period listed are encou...
Zur Nachricht
Hims & Hers Health
Charts & Research Termsheets Terminal
Permalink
Mo., 25.08.2025       Hims & Hers Health
US4330001060

LOS ANGELES, Aug. 25, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Hims & Hers Health, Inc. ("Hims & Hers" or "the Company") (NYSE: HIMS) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated ther...
Zur Nachricht
Hims & Hers Health
Charts & Research Termsheets Terminal
Permalink
Mo., 25.08.2025       Hims & Hers Health
US4330001060

LOS ANGELES, Aug. 25, 2025 /PRNewswire/ -- The DJS Law Group announces that it is investigating claims on behalf of investors of Hims & Hers Health, Inc. ("Hims & Hers" or "the Company") (NYSE: HIMS) for violations of the securities laws. INVESTIGATION DETAILS: The investigation focuses on whether the Company issued misleading statements...
Zur Nachricht
Hims & Hers Health
Charts & Research Termsheets Terminal
Permalink
Sa., 23.08.2025       Hims & Hers Health
US4330001060

NEW YORK, Aug. 23, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Hims & Hers Health, Inc. (NYSE: HIMS) between April 29, 2025 and June 23, 2025, both dates in...
Zur Nachricht
Hims & Hers Health
Charts & Research Termsheets Terminal
Permalink
Fr., 22.08.2025       Hims & Hers Health
US4330001060

Kahn Swick & Foti, LLC (“KSF”) and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until August 25, 2025 to file lead plaintiff applications in securities class action lawsuits against Hims & Hers Health, Inc. (“Hims” or the “Company”) (NYSE: HIMS), if they purchased the Company’...
Zur Nachricht
Hims & Hers Health
Charts & Research Termsheets Terminal
Permalink
Fr., 22.08.2025       Hims & Hers Health
US4330001060

NEW ORLEANS, Aug. 22, 2025 /PRNewswire/ -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until August 25, 2025 to file lead plaintiff applications in securities class action lawsuits against Hims & Hers Health, Inc. ("Hims" or the "Company") (NYSE: HIMS), if they purchased the Company's securities betwe...
Zur Nachricht
Hims & Hers Health
Charts & Research Termsheets Terminal
Permalink
Fr., 22.08.2025       Hims & Hers Health
US4330001060

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Hims To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Hims between April 29, 2025 and June 22, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wil...
Zur Nachricht
Hims & Hers Health
Charts & Research Termsheets Terminal
Permalink
Fr., 22.08.2025       Hims & Hers Health
US4330001060

NEW YORK, Aug. 22, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Hims & Hers Health, Inc. ("Hims & Hers" or the "Company") (NYSE: HIMS). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire...
Zur Nachricht
Hims & Hers Health
Charts & Research Termsheets Terminal
Permalink
Fr., 22.08.2025       Hims & Hers Health
US4330001060

RADNOR, Pa., Aug. 22, 2025 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that securities class action lawsuits have been filed in the United States District Court for the Northern District of California against Hims & Hers Health, Inc. ("Hims & Hers") (NYSE: HIMS) on behalf of thos...
Zur Nachricht
Hims & Hers Health
Charts & Research Termsheets Terminal
Permalink
Fr., 22.08.2025       Hims & Hers Health
US4330001060

NEW YORK, Aug. 22, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Hims & Hers Health, Inc. ("Hims & Hers Health, Inc." or the "Company") (NYSE: HIMS) of a class action securities lawsuit. CLASS DEFINIT...
Zur Nachricht
Hims & Hers Health
Charts & Research Termsheets Terminal
Permalink
Do., 21.08.2025       Hims & Hers Health
US4330001060

LOS ANGELES, Aug. 21, 2025 /PRNewswire/ -- Glancy Prongay & Murray LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against Hims & Hers Health, Inc. ("Hims" or the "Company") (NYSE: HIMS)....
Zur Nachricht
Hims & Hers Health
Charts & Research Termsheets Terminal
Permalink
Do., 21.08.2025       Hims & Hers Health
US4330001060

  LOS ANGELES, Aug. 21, 2025 /PRNewswire/ -- The DJS Law Group announces that it is investigating claims on behalf of investors of Hims & Hers Health, Inc. ("Hims & Hers" or "the Company") (NYSE: HIMS) for violations of the securities laws. INVESTIGATION DETAILS: The investigation focuses on whether the Company issued misleading statemen...
Zur Nachricht
Hims & Hers Health
Charts & Research Termsheets Terminal
Permalink
Do., 21.08.2025       Hims & Hers Health
US4330001060

NEW YORK, Aug. 21, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Hims & Hers Health, Inc. (NYSE: HIMS). Shareholders who purchased shares of HIMS during the class period listed are encou...
Zur Nachricht
Hims & Hers Health
Charts & Research Termsheets Terminal
Permalink
Do., 21.08.2025       Hims & Hers Health
US4330001060

SAN DIEGO, Aug. 21, 2025 /PRNewswire/ -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Hims & Hers Health, Inc. (NYSE: HIMS) securities between April 29, 2025 and June 23, 2025, all dates inclusive (the "Class Period"), have until this Monday, August 25, 2025 to seek appointment as lead plaintiff of the Hims &...
Zur Nachricht
Hims & Hers Health
Charts & Research Termsheets Terminal
Permalink
Do., 21.08.2025       Hims & Hers Health
US4330001060

LOS ANGELES, Aug. 21, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Hims & Hers Health, Inc. ("Hims & Hers" or "the Company") (NYSE: HIMS) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated ther...
Zur Nachricht
Hims & Hers Health
Charts & Research Termsheets Terminal
Permalink
Mi., 20.08.2025       Hims & Hers Health
US4330001060

LOS ANGELES, Aug. 20, 2025 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to Hims & Hers Health, Inc. ("Hims" or the "Company") (NYSE: HIMS) have opportunity to lead the securities fraud class action lawsuit....
Zur Nachricht
Hims & Hers Health
Charts & Research Termsheets Terminal
Permalink
Mi., 20.08.2025       Hims & Hers Health
US4330001060

PHILADELPHIA, Aug. 20, 2025 /PRNewswire/ -- Berger Montague, a national securities litigation law firm, is investigating potential securities fraud claims against Hims & Hers Health Inc. ("Hims & Hers" or the "Company") (NYSE: HIMS). The firm is examining whether Hims & Hers, during the Class Period from April 29, 2025 through June 22...
Zur Nachricht
Hims & Hers Health
Charts & Research Termsheets Terminal
Permalink
Di., 19.08.2025       Hims & Hers Health
US4330001060

NEW YORK, Aug. 19, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Hims & Hers Health, Inc. ("Hims & Hers Health, Inc." or the "Company") (NYSE: HIMS) of a class action securities lawsuit. CLASS DEFINIT...
Zur Nachricht
Hims & Hers Health
Charts & Research Termsheets Terminal
Permalink
Di., 19.08.2025       Hims & Hers Health
US4330001060

NEW YORK, Aug. 18, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Hims & Hers Health, Inc. (NYSE: HIMS) between April 29, 2025 and June 23, 2025, both dates in...
Zur Nachricht
Hims & Hers Health
Charts & Research Termsheets Terminal
Permalink
Mo., 18.08.2025       Hims & Hers Health
US4330001060

NEW YORK, Aug. 18, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Hims & Hers Health, Inc. (NYSE: HIMS). Shareholders who purchased shares of HIMS during the class period listed are encou...
Zur Nachricht
Hims & Hers Health
Charts & Research Termsheets Terminal
Permalink